The World Health Organisation has given its approval for the R21/Matrix malaria vaccine, a ground-breaking development in the battle against malaria. Developed by the University of Oxford and the Serum Institute of India, this cost-effective vaccine is set to be mass-produced in India. Malaria remains a significant global health challenge, causing millions of cases and deaths annually, particularly in Africa and India. Why has it been historically challenging to develop an effective malaria vaccine, and what makes the R21 vaccine a promising breakthrough?

How ‘made in India’ vaccine will combat malaria | The India Story

The World Health Organisation has given its approval for the R21/Matrix malaria vaccine, a ground-breaking development in the battle against malaria. Developed by the University of Oxford and the Serum Institute of India, this cost-effective vaccine is set to be mass-produced in India.

WHO recommends second Malaria vaccine; could Malaria finally be eradicated?

Ghana has approved Oxford's new vaccine for Malaria. The new vaccine is considered the best compared to the earlier versions. What is so special about this vaccine? Molly Gambhir brings you a report.

Gravitas: Ghana approves Oxford's new malaria vaccine

A University of Oxford developed and Serum Institute of India (SII) manufactured and scaled up "high efficacy" malaria vaccine has been licensed for use in Ghana by Africa's Food and Drugs Authority, the university announced here on Thursday.

Oxford University, Serum Institute of India tie-up delivers 'high efficacy' malaria vaccine

The United Nations Children’s Fund (UNICEF), with its aim to fight malaria, has awarded GSK, a pharmaceutical firm, the first ever supply of a malaria vaccine with a potential value of $170 million.

‘We hope this is just the beginning’: UNICEF secures first malaria vaccine supply, says will benefit millions

World Malaria Day 2022: From causes to who all are at risk, here's all you need to know

Malaria endemic in western Kenya has received a new vaccine against Malaria, which kills around 260 000 children under 5 every year in Sub-Saharan Africa. The groundbreaking drug was 30 years in the making, and a pilot program has been rolling out the drug in Kenya, Ghana, and Malawi since 2019.

Kenya: Malaria vaccine gives thousands a hope for better life

Coronavirus pandemic has ruined several lives and caused some major disruptions around the world. Following the same scare, the World Health Organization (WHO) has revealed that tens of thousands of additional malaria-related deaths were reported in 2020 due to pandemic disruptions.

Coronavirus pandemic resulted in alarming increase in malaria deaths: WHO

WHO has recommended World's first Malaria vaccine for Children. Malaria has been killing humans since Mesopotamian civilisation. Why did it take so long to develop a vaccine? Is it because Malaria mostly affects Africa and not the West? Listen in to Palki Sharma

Gravitas: WHO recommends first Malaria vaccine for children

When babies are born in western Kenya, where malaria is rife, many mothers are sent home from the hospital with one all-important baby gift: a bed net treated with insecticide.

Africans welcome new Malaria vaccine. But is it a ‘game changer'?

The World Health Organisation (WHO) has approved the first malaria vaccine RTS, S/AS01 in the world. It will start from African countries that are affected the most.

WHO approves first-ever malaria vaccine in major breakthrough

The RTS,S/AS01 malaria vaccine was recommended by the World Health Organisation on Wednesday, making it the first vaccination against the mosquito-borne illness that kills over 400,000 people each year, primarily African children.

What is Mosquirix, the world's first malaria vaccine WHO recommends?

The World Health Organization on Wednesday endorsed the RTS,S/AS01 malaria vaccine, the first against the mosquito-borne disease that kills more than 400,000 people a year, mostly African children.

WHO recommends use of first malaria vaccine for children

According to a report by a team of researchers from the University of Oxford and their partners, R21/Matrix-M, a malaria vaccine which was in its Phase IIb trial, showed an efficacy of 77 per cent over a period of 12 months.

World’s first malaria vaccine to achieve WHO-specified efficacy developed in UK

Britain`s GSK will shift production of the world`s first effective malaria vaccine to Indian COVID-19 vaccine developer Bharat Biotech, as part of global efforts to battle the deadly fever, the drugmakers said on Wednesday.

GSK to move malaria vaccine production to India's Bharat Biotech

The Oxford team behind a successful COVID-19 vaccine candidate will soon enter the final stage of human trials in a jab against malaria. Scientists at Oxford University’s Jenner Institute have been working on both vaccines.

Scientists behind Oxford Covid vaccine to soon start final trials of Malaria jab

How Malaria vaccine can save Africa, Asia from killer disease

Kenya gets Malaria Vaccine after Ghana and Malawi. To know more watch the video.

World's first Malaria Vaccine introduced in Kenya

malaria-vaccine

Malaria Vaccine, News on Malaria Vaccine, stories on Malaria Vaccine, articles on Malaria Vaccine, Malaria Vaccine stories at Wion, Malaria Vaccine news, Malaria Vaccine latest news